Kane Slutzkin

Stock Analyst at Deutsche Bank

(2.82)
# 2,848
Out of 4,651 analysts
34
Total ratings
52.2%
Success rate
6.6%
Average return

Stocks Rated by Kane Slutzkin

Hikma Pharmaceuticals PLC
Aug 7, 2026
Reiterated: Buy
Price Target: 1,950p
Current: 1,640p
Upside: +18.90%
Smith & Nephew plc
Aug 6, 2026
Maintained: Hold
Price Target: 1,400p1,250p
Current: 1,096p
Upside: +14.05%
Oxford Nanopore Technologies plc
Jul 21, 2026
Maintained: Buy
Price Target: 195p
Current: 122p
Upside: +59.84%
IP Group Plc
Mar 18, 2026
Maintained: Buy
Price Target: 103p110p
Current: 69p
Upside: +58.73%
NIOX Group Plc
Jan 21, 2026
Maintained: Buy
Price Target: 86p
Current: 68p
Upside: +27.22%
Oxford Biomedica plc
Jan 6, 2026
Upgraded: Buy
Price Target: 735p
Current: 487p
Upside: +50.92%
CVS Group plc
Oct 21, 2025
Reiterated: Buy
Price Target: 1,500p1,700p
Current: 1,307p
Upside: +30.07%
Medicover AB (publ)
Sep 26, 2025
Maintained: Hold
Price Target: kr 265.00
Current: kr 236.00
Upside: +12.29%
Spire Healthcare Group plc
Sep 22, 2025
Maintained: Buy
Price Target: 300p
Current: 234p
Upside: +28.21%
Uniphar plc
Jul 30, 2025
Reiterated: Hold
Price Target: 375p
Current: 365p
Upside: n/a
Reiterated: Buy
Price Target: 275p
Current: 281p
Upside: n/a
Downgraded: Hold
Price Target: 440p400p
Current: 420p
Upside: n/a
Maintained: Buy
Price Target: 315p
Current: 230p
Upside: n/a